T. Rowe Price Investment Management Inc. Has $181.44 Million Holdings in Cognex Corporation $CGNX

Key Points

• T. Rowe Price Investment Management Inc. increased its stake in Cognex Corporation by 32.0% in the first quarter, now owning approximately 3.62% of the company, valued at $181.4 million.
• A number of analysts have recently upgraded their ratings on Cognex, with KeyCorp setting a new price target of $50.00, indicating positive market sentiment.
• Cognex announced a quarterly dividend of $0.08 per share, representing an annualized yield of 0.7%, with the dividend payout ratio currently at 45.07%.

T. Rowe Price Investment Management Inc. raised its holdings in Cognex Corporation (NASDAQ:CGNX - Free Report) by 32.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,082,319 shares of the scientific and technical instruments company's stock after buying an additional 1,474,832 shares during the quarter. T. Rowe Price Investment Management Inc. owned 3.62% of Cognex worth $181,436,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Mackenzie Financial Corp grew its stake in shares of Cognex by 126.2% in the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after acquiring an additional 2,571,457 shares during the last quarter. Lazard Asset Management LLC boosted its holdings in Cognex by 1.1% in the 4th quarter. Lazard Asset Management LLC now owns 2,256,640 shares of the scientific and technical instruments company's stock valued at $80,923,000 after purchasing an additional 25,492 shares during the period. Bank of New York Mellon Corp grew its position in Cognex by 1.9% in the 1st quarter. Bank of New York Mellon Corp now owns 2,131,538 shares of the scientific and technical instruments company's stock worth $63,584,000 after purchasing an additional 38,857 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Cognex by 6.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,902,930 shares of the scientific and technical instruments company's stock worth $68,239,000 after purchasing an additional 117,089 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Cognex by 35.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,891,602 shares of the scientific and technical instruments company's stock valued at $67,834,000 after buying an additional 497,341 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently weighed in on CGNX. DA Davidson lifted their target price on Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. KeyCorp raised Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price objective on the stock in a report on Friday, August 1st. TD Cowen upgraded Cognex from a "hold" rating to a "buy" rating and set a $35.00 target price for the company in a research note on Monday, April 28th. Robert W. Baird raised their target price on Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research report on Monday, June 16th. Finally, Cowen upgraded shares of Cognex from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $42.31.

Cognex Price Performance

Shares of CGNX traded up $0.20 during trading hours on Tuesday, hitting $44.22. The stock had a trading volume of 697,942 shares, compared to its average volume of 2,094,566. The stock has a market capitalization of $7.42 billion, a price-to-earnings ratio of 62.27 and a beta of 1.47. The company's fifty day moving average is $36.12 and its two-hundred day moving average is $32.08. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $45.03.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million for the quarter, compared to analysts' expectations of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Equities analysts predict that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th will be given a $0.08 dividend. The ex-dividend date is Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex's payout ratio is presently 45.07%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.